Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Blocking YAP/TAZ could be a new way to treat skin cancer.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.